Biogen abandons Alzheimer’s drug Aduhelm to focus on Leqembi
Biogen, a US-based biotechnology company, will discontinue the development and commercialisation of its Alzheimer’s treatment and terminate its post-approval study as it failed
Biogen, a US-based biotechnology company, will discontinue the development and commercialisation of its Alzheimer’s treatment and terminate its post-approval study as it failed
Physicians and scientists are on the lookout for a new non-invasive diagnostic process for a lesser-known condition called adenomyosis in women.
The UN Secretary-General António Guterres met with 35 donor nations and appealed for the restoration of funds to a UN body working for
More than 35 million people may have cancer in 2050 — an increase of 77% from 20 million new cases in 2022, according
Elon Musk’s Neuralink Corp., has implanted a device in a human brain and the results show “promising neutron spike detection,” according to an
By K. Leelamoni January 30, 2024: Globally, we find that for the last few decades, there has been a shift towards non-communicable diseases
HQ Team January 29, 2024: Fasting diets (FDs) have gained popularity for their impact on health, disease, and weight control. Despite the vast
Bharti Jayshankar January 29, 2024: Kayrros, an environment intelligence company, has identified the world’s 1,300 largest methane-polluting sites from space with its satellite surveillance.
HQ Team January 27, 2024: The national public health agency of the US has issued a nationwide alert to healthcare providers to track